Skip to content

A collaborative primary care-based approach to managing upper respiratory tract infections as a strategy to reduce antibiotic prescribing

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN18154381
Enrollment
7500
Registered
2006-09-21
Start date
2005-03-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper Respiratory Tract Infections Respiratory Upper Respiratory Tract Infections

Interventions

Intervention community pharmacists will assess patients referred from General Practitioner (GP) practices using the Network Organisation Technology Research Center (CENTOR) algorithm to assist them in

Sponsors

Queen's University Belfast (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. General practices with between 3,000 to 8,000 and over 8,000 patients and complete computerised prescribing 2. Community pharmacists who dispense 80% of issued prescriptions 3. Patients: a. aged over five years b. who request an appointment or prescription for an URTI c. who use one of the participating pharmacies d. who do not have a history of chronic respiratory or cardiac disease e. who have not previously consulted with a pharmacist about their current symptoms

Exclusion criteria

Exclusion criteria: 1. General Practices with less than 2,500 patients and incomplete computerised prescribing 2. Community pharmacists who dispense less than 80% of issued prescriptions 3. Patients: a. aged under 5 years b. who do not use one of the participating pharmacies c. who have a history of chronic respiratory or cardiac disease d. who have previously consulted with a pharmacist about their current symptoms

Design outcomes

Primary

MeasureTime frame
The rate of antibiotic prescribing for URTIs.

Secondary

MeasureTime frame
1. Comparison of treatment success rates of URTIs between Intervention and Control groups 2. Patient satisfaction with URTI management 3. Economic analysis of the cost of the new pharmacy service

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026